SCHEMBL17875909

SCHEMBL17875909

c1ccc(-c2cc(-c3ccc4c(c3)-c3cc(-c5cccc6oc7ccccc7c56)ccc3COC4)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.38
BACE1 P56817 1/20 0.34
MAPT P10636 2/20 0.34
MAPK1 P28482 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PLAUR Q03405 2/20 0.33
ALOX5 P09917 1/20 0.33
THRB P10828 1/20 0.32
PLA2G2A P14555 3/20 0.32
PLA2G4A P47712 3/20 0.32
PLA2G10 O15496 1/20 0.32
PRKDC P78527 2/20 0.31
ENPP3 O14638 1/20 0.31
ACACA Q13085 1/20 0.30
PIM1 P11309 1/20 0.30
CSNK2A2 P19784 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875872 0.96 HSP90AA1 (0.38) HSP90AA1BACE1MAPTMAPK1KDM4E
SCHEMBL17875853 0.96 HSP90AA1 (0.38) HSP90AA1BACE1MAPTMAPK1KDM4E
SCHEMBL17875915 0.90 PLA2G2A (0.39) HSP90AA1BACE1HPGDALOX5PLA2G2A
SCHEMBL17875891 0.88 ALOX5 (0.47) HSP90AA1MAPTMAPK1KDM4EALDH1A1
SCHEMBL17875801 0.88 BACE1 (0.34) BACE1MAPTMAPK1KDM4EALDH1A1
SCHEMBL17875897 0.87 HCRTR1 (0.36) HSP90AA1MAPTMAPK1KDM4EALDH1A1
SCHEMBL17875914 0.87 PLA2G2A (0.37) HSP90AA1MAPTMAPK1KDM4EALDH1A1
SCHEMBL17875908 0.87 ALOX5 (0.40) HSP90AA1BACE1MAPTKDM4EALDH1A1
SCHEMBL17876008 0.86 BACE1 (0.33) HSP90AA1BACE1MAPTMAPK1KDM4E
SCHEMBL17875850 0.85 PLA2G2A (0.36) HSP90AA1BACE1MAPTL3MBTL1ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 HSP90AA1 4363/4885BACE1 709/4885MAPT 2144/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 HSP90AA1 4363/4885BACE1 709/4885MAPT 2144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.